Oncothyreon Inc. News Headlines

ONTY 
$1.8
*  
0.03
1.64%
Get ONTY Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading ONTY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Biotech Weekly: Top Ideas From The San Antonio Breast Cancer Symposium
12/16/2014 11:00:00 AM - Seeking Alpha


Oncothyreon Up on Gaining License to Oncology Candidate - Analyst Blog
12/15/2014 6:05:00 PM - Zacks.com


Oncothyreon Up on Gaining License to Oncology Candidate - Analyst Blog
12/15/2014 6:05:00 AM - Investopedia


CCXI Swells On Trial Data, PETM Taken Private, Genmab Gets Richer, Onus On ONTY
12/15/2014 12:13:00 AM - RTT News


Health Care Sector Update for 12/12/2014: SNY, MEIP, ONTY
12/12/2014 8:43:04 AM - MT Newswires


Oncothyreon Announces Exclusive License Deal With Array BioPharma For ONT-380
12/12/2014 7:30:00 AM - RTT News


Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape
11/28/2014 8:44:00 AM - Zacks.com


Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape
10/7/2014 7:44:00 AM - Zacks.com


Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape
10/6/2014 7:44:00 AM - Zacks.com


Will Oncothyreon (ONTY) Crush Estimates at Its Next Earnings Report? - Tale of the Tape
9/16/2014 7:32:00 AM - Zacks.com


Sector Update: Health-Care Shares Lower Pre-Market
9/12/2014 7:47:10 AM - MT Newswires


Sector Update: Health Care
9/12/2014 7:46:08 AM - MT Newswires


Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
8/20/2014 2:53:00 PM - Zacks.com


Oncothyreon (ONTY) is Oversold: Can It Recover? - Tale of the Tape
8/20/2014 8:36:24 AM - Zacks.com


Tuesday Sector Laggards: Precious Metals, Biotechnology Stocks
8/19/2014 12:50:00 PM - BNK Invest


Pre-Market Most Active for Aug 19, 2014 : NOK, JRJC, ONTY, BHP, ERIC, RDEN, BBL, AAPL, HD, TVIX, ARO, DKS
8/19/2014 7:39:58 AM - NASDAQ.com News


Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss - Analyst Blog
8/15/2014 8:40:00 AM - Zacks.com


Earnings Reaction History: Oncothyreon Inc., 75.0% Follow-Through Indicator, 5.7% Sensitive
8/11/2014 10:50:11 AM - MT Newswires


Wednesday Sector Leaders: Biotechnology, Paper & Forest Products
7/23/2014 1:24:17 PM - BNK Invest


Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
6/6/2014 1:45:00 PM - Seeking Alpha


Oncothyreon Collaborates with Celldex - Analyst Blog
5/30/2014 3:40:00 PM - Zacks.com


Healthcare Stocks Climbing in Late Trade; Celldex, Oncothyreon Partnering on Prospective Cancer Treatment
5/29/2014 2:53:26 PM - MT Newswires


Sector Update: Healthcare
5/29/2014 2:52:18 PM - MT Newswires


As Investors Laud Combination Therapies, Oncothyreon's Pipeline Could Come Into Focus
4/24/2014 10:25:00 AM - Seeking Alpha


Merck KGaA Starts Study on Tecemotide - Analyst Blog
4/8/2014 5:55:01 PM - Zacks.com